|
EIF4G1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.014300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.816200E-04 |
| Normal-vs-Stage2 |
1.129440E-01 |
| Normal-vs-Stage3 |
1.817920E-02 |
| Normal-vs-Stage4 |
2.997800E-03 |
| Stage1-vs-Stage2 |
3.629200E-01 |
| Stage1-vs-Stage3 |
3.321800E-01 |
| Stage1-vs-Stage4 |
9.014800E-01 |
| Stage2-vs-Stage3 |
8.436400E-01 |
| Stage2-vs-Stage4 |
3.868000E-01 |
| Stage3-vs-Stage4 |
4.057600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.750600E-04 |
| Normal-vs-AfricanAmerican |
9.075600E-03 |
| Normal-vs-Asian |
3.969300E-04 |
| Caucasian-vs-AfricanAmerican |
7.805600E-01 |
| Caucasian-vs-Asian |
1.373250E-01 |
| AfricanAmerican-vs-Asian |
4.502400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.743200E-03 |
| Normal-vs-Female |
5.218300E-04 |
| Male-vs-Female |
9.551000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.197400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.200600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.402500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.271600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.779000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.407570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.282970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.867600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.267200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.447400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.755800E-01 |
| Classical-VS-Follicular |
4.40680003599425E-09 |
| Classical-VS-Other |
8.694100E-02 |
| Classical-VS-Normal |
5.32039999945333E-07 |
| Tall-VS-Follicular |
1.57181999999034E-05 |
| Tall-VS-Other |
6.055700E-02 |
| Tall-VS-Normal |
3.993400E-04 |
| Follicular-VS-Other |
5.769800E-01 |
| Follicular-VS-Normal |
1.723020E-01 |
| Other-VS-Normal |
9.472200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.950140E-02 |
| Normal-vs-N1 |
1.653710E-02 |
| N0-vs-N1 |
4.960800E-01 |
|
|
